Bausch Health Companies Inc.: Conjunctivitis trials

The registry lists 24 Conjunctivitis studies with Bausch Health Companies Inc. as lead sponsor. 0 are open to participants now and 20 have results posted.

Phase 1 1Phase 2 6Phase 3 16Phase 4 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedNCT05579730Phase 3Results posted
• A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and VehicleCompletedNCT03489941Phase 3Results posted
• Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial ConjunctivitisTerminatedNCT01740388Phase 3Results posted
• Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)CompletedNCT01435460Phase 3Results posted
• Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial ConjunctivitisTerminatedNCT01330355Phase 3Results posted
• Mapracorat Ophthalmic Formulation in Subjects With Allergic ConjunctivitisCompletedNCT01289431Phase 2Results posted
• Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to VehicleCompletedNCT01175590Phase 3Results posted
• Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis PatientsCompletedNCT01174823Phase 2Results posted
• Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy VolunteersCompletedNCT01159015Phase 3Results posted
• Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen ChallengeCompletedNCT01107405Phase 2Results posted
• Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of BlepharokeratoconjunctivitisCompletedNCT01028027Phase 3Results posted
• Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial ConjunctivitisCompletedNCT00972777Phase 2/3Results posted
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.CompletedNCT00770133Phase 3Results posted
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.CompletedNCT00769886Phase 3Results posted
• Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric BlepharoconjunctivitisCompletedNCT00705159Phase 4Results posted
• Clinical and Microbial Efficacy of ISV403 in Bacterial ConjunctivitisCompletedNCT00622908Phase 2Results posted
• Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic ConjunctivitisCompletedNCT00586664Phase 3Results posted
• Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal VolunteersCompletedNCT00586625Phase 3Results posted
• A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial ConjunctivitisCompletedNCT00348348Phase 3Results posted
• A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.CompletedNCT00347932Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%CompletedNCT01437982Phase 4
• Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic ConjunctivitisCompletedNCT00423007Phase 3
• Systemic Pharmacokinetics of BOL-303224-ACompletedNCT00407589Phase 1
• A Study Of The Safety And Effectiveness Of A New Treatment For Allergic ConjunctivitisWithdrawnNCT00375596Phase 2